Holen Sie sich die Stockscreener-App
4.455
2.41%
0.105
Schlusskurs vom Vortag:
$4.35
Offen:
$4.41
24-Stunden-Volumen:
3,264
Relative Volume:
0.03
Marktkapitalisierung:
$8.00M
Einnahmen:
$9.26M
Nettoeinkommen (Verlust:
$-941.60K
KGV:
-61.88
EPS:
-0.072
Netto-Cashflow:
$-2.65M
1W Leistung:
-1.66%
1M Leistung:
-14.33%
6M Leistung:
+49.50%
1J Leistung:
+52.62%
1-Tages-Spanne:
$4.41
$4.515
1-Wochen-Bereich:
$4.35
$4.94
52-Wochen-Spanne:
$2.0068
$15.60
Bionexus Gene Lab Corp Stock (BGLC) Company Profile
Firmenname
Bionexus Gene Lab Corp
Sektor
Branche
Telefon
1-307-241-6898
Adresse
10-2 TOWER B, VERTICAL BUSINESS SUITE,, KUALA LUMPUR
Vergleichen Sie BGLC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BGLC
BioNexus Gene Lab Corp Common stock
|
0.343 | 201.51M | 0 | 0 | 0 | 0.00 |
|
MOBBW
Mobilicom Limited Warrants
|
2.15 | 3.06B | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
19.51 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
4.15 | 166.65M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.22 | 492.74M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
0.72 | 0 | 0 | 0 | 0 | 0.00 |
Bionexus Gene Lab Corp Aktie (BGLC) Neueste Nachrichten
How interest rate cuts could boost BioNexus Gene Lab Corp. stock2025 Geopolitical Influence & Reliable Volume Spike Alerts - newser.com
Will BioNexus Gene Lab Corp. stock outperform growth indexesDividend Hike & Real-Time Stock Entry Alerts - newser.com
Why BioNexus Gene Lab Corp. stock remains a top recommendation2025 Top Decliners & Proven Capital Preservation Methods - newser.com
Is BioNexus Gene Lab Corp. stock reversal real or fakeDay Trade & Breakout Confirmation Trade Signals - newser.com
Will BioNexus Gene Lab Corp. stock outperform Nasdaq indexQuarterly Portfolio Summary & Weekly Setup with High ROI Potential - newser.com
Is BioNexus Gene Lab Corp. stock bottoming out2025 Price Momentum & Daily Market Momentum Tracking - newser.com
Why BioNexus Gene Lab Corp. stock is in analyst buy zoneEarnings Beat & AI Enhanced Trading Alerts - newser.com
Chart based exit strategy for BioNexus Gene Lab Corp.July 2025 Decliners & Consistent Growth Equity Picks - newser.com
Chart overlay techniques for tracking BioNexus Gene Lab Corp.2025 Trading Recap & Real-Time Chart Pattern Alerts - newser.com
Pattern recognition hints at BioNexus Gene Lab Corp. upsideTake Profit & Fast Entry High Yield Tips - newser.com
BioNexus Gene Lab Corp. stock chart pattern explained2025 Valuation Update & Fast Exit and Entry Trade Guides - newser.com
Is BioNexus Gene Lab Corp. stock a buy before product launchesWeekly Risk Summary & Precise Buy Zone Tips - newser.com
Using portfolio simulators with BioNexus Gene Lab Corp. includedEarnings Overview Report & Capital Efficiency Focused Strategies - newser.com
What MACD signals say about BioNexus Gene Lab Corp.Quarterly Profit Summary & High Accuracy Investment Entry Signals - newser.com
BioNexus Gene Lab Corp SEC 10-Q Report - TradingView
What to do if you’re stuck in BioNexus Gene Lab Corp.Weekly Market Outlook & Expert Verified Stock Movement Alerts - newser.com
Is BioNexus Gene Lab Corp. stock a smart buy before Fed meeting2025 EndofYear Setup & Risk Controlled Stock Pick Alerts - Fundação Cultural do Pará
Check Out BioNexus Gene Lab Corp (BGLC)’s Trade Data Rather Than the Analysts’ Views - setenews.com
BioNexus Gene Lab Corp. (Nasdaq: BGLC) Announces Strategic Agreements with Fidelion Diagnostics for Southeast Asia MRD Commercialization - BioSpace
BioNexus Gene Lab forms partnership to commercialize liquid biopsy platform By Investing.com - Investing.com Nigeria
BioNexus Gene Lab Corp. (Nasdaq: BGLC) Announces Strategic - GlobeNewswire
BioNexus Gene Lab Corp. Announces Strategic Agreements with Fidelion Diagnostics Pte. Ltd. and Tongshu Biotechnology (Hong Kong) Co., Limited for Southeast Asia MRD Commercialization - MarketScreener
BGLC Stock Tumbled Over 13% Today: Why Is VitaGuard Commercialization Agreement Drawing Investor Attention? - Asianet Newsable
BioNexus Gene Lab forms partnership to commercialize liquid biopsy platform - Investing.com India
BioNexus Gene Lab stock soars after strategic MRD testing agreements By Investing.com - Investing.com Philippines
BioNexus Gene Lab stock soars after strategic MRD testing agreements - Investing.com
Finanzdaten der Bionexus Gene Lab Corp-Aktie (BGLC)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.54%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):